FDA Drug Application (204785) for TREZIX by WRASER PHARMS LLC

Back to FDA Applications sponsored by WRASER PHARMS LLC

Application Number204785
Product Number001
FormCAPSULE;ORAL
Dosage320.5MG;30MG;16MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTREZIX
Active IngredientACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE

Active IngredientCount
List of drugs with Active Ingredient ACETAMINOPHEN107
List of drugs with Active Ingredient CAFFEINE44
List of drugs with Active Ingredient DIHYDROCODEINE BITARTRATE6


Back to FDA Applications sponsored by WRASER PHARMS LLC